Mangoceuticals (MGRX) Institutional Ownership $2.49 -0.08 (-3.11%) Closing price 04/21/2025 04:00 PM EasternExtended Trading$2.44 -0.05 (-1.81%) As of 08:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Mangoceuticals (NASDAQ:MGRX)CurrentInstitutional OwnershipPercentage56.72%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$46.38MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.32M Get MGRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Mangoceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MGRX Institutional Buying and Selling by Quarter Mangoceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025Geode Capital Management LLC12,003$29K0.0%-90.9%0.482% 2/4/2025Ackerman Capital Advisors LLC34,500$83K0.0%-96.0%1.386% 10/24/2024Ackerman Capital Advisors LLC873,356$206K0.1%N/A3.519% 8/8/2023Colonial River Wealth Management LLC36,100$66K0.0%N/A0.216% 7/28/2023Independent Advisor Alliance26,000$48K0.0%N/A0.162% (Data available from 1/1/2016 forward) MGRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MGRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Mangoceuticals shares: Ackerman Capital Advisors LLC ($83K), Colonial River Wealth Management LLC ($66K), and Independent Advisor Alliance ($48K), Geode Capital Management LLC ($29K).Learn more on MGRX's institutional investors. What percentage of Mangoceuticals stock is owned by institutional investors? 56.72% of Mangoceuticals stock is owned by institutional investors. Learn more on MGRX's institutional investor holdings. Which institutional investors have been buying Mangoceuticals stock? The following institutional investors have purchased Mangoceuticals stock in the last 24 months: Ackerman Capital Advisors LLC ($873.36K), Colonial River Wealth Management LLC ($36.10K), and Independent Advisor Alliance ($26K). How much institutional buying is happening at Mangoceuticals? Institutional investors have bought a total of 935,456 shares in the last 24 months. This purchase volume represents approximately $71.94M in transactions. Which Mangoceuticals major shareholders have been selling company stock? The following institutional investors have sold Mangoceuticals stock in the last 24 months: Ackerman Capital Advisors LLC ($838.86K), and Geode Capital Management LLC ($119.32K). How much institutional selling is happening at Mangoceuticals? Institutional investors have sold a total of 958,180 shares in the last 24 months. This volume of shares sold represents approximately $2.32M in transactions. Related Companies OPGN Major Shareholders BNR Major Shareholders CCM Major Shareholders ENZ Major Shareholders BRTX Major Shareholders KDLY Major Shareholders SSY Major Shareholders ACON Major Shareholders ATIP Major Shareholders BGLC Major Shareholders This page (NASDAQ:MGRX) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersElon’s 2025 Silver Crisis (What It Means for You)Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. Wi...GoldenCrest Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCould this be my downfall?I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MGRX Stock Free MGRX Stock Alerts